4Dxaccuplex
Antibody product name |
|||
| ProductCode | TRI Biotech | Pack Size | Ask for price |
Human IgG antibody Laboratories manufactures the 4dxaccuplex reagents distributed by Genprice. The 4Dxaccuplex reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SeraCare Inc.. Other 4Dxaccuplex products are available in stock. Specificity: 4Dxaccuplex Category:
L-NAME hydrochloride |
||
| Glentham Life Sciences | 1g | EUR 159.23 |
L-NAME (hydrochloride) |
||
| MedChemExpress | 500mg | EUR 183.6 |
L-NAME hydrochloride |
||
| Glentham Life Sciences | 1 | EUR 15.9 |
L-NAME hydrochloride |
||
| Glentham Life Sciences | 1 g | EUR 55.2 |
L-NAME hydrochloride |
||
| Glentham Life Sciences | 25 | EUR 174 |
L-NAME hydrochloride |
||
| Glentham Life Sciences | 25 g | EUR 246 |
L-NAME hydrochloride |
||
| Glentham Life Sciences | 5 | EUR 55.4 |
DX3-235 |
|||
| T64108-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: DX3-235 |
|||
DX3-235 |
|||
| T64108-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: DX3-235 |
|||
DX2-201 |
|||
| HY-145303 | MedChemExpress | Get quote | Ask for price |
|
Description: DX2-201 is a potent and selective oxidative phosphorylation (OXPHOS) complex I inhibitor with an IC50 of 312 nM. DX2-201 has anticancer effects[1]. |
|||
DX3-235 |
|||
| HY-145304 | MedChemExpress | Get quote | Ask for price |
|
Description: DX3-235 is an oxidative phosphorylation (OXPHOS) inhibitor. DX3-235 shows nanomolar inhibition of complex I function and ATP production in a galactose-containing medium resulting in significant cytotoxicity[1]. |
|||
DX3-234 |
|||
| HY-145306 | MedChemExpress | Get quote | Ask for price |
|
Description: DX3-234 is an oxidative phosphorylation (OXPHOS) inhibitor. DX3-234 shows significant tumor suppression in the Pan02 syngeneic model of pancreatic cancer[1]. |
|||
DX3-213B |
|||
| 465831 | MedKoo Biosciences | 1.0mg | EUR 250 |
DX3-213B |
|||
| T63136-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: DX3-213B |
|||
DX3-213B |
|||
| T63136-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: DX3-213B |
|||
DX3-213B |
|||
| T63136-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: DX3-213B |
|||
DX3-213B |
|||
| T63136-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: DX3-213B |
|||
DX3-213B |
|||
| T63136-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: DX3-213B |
|||
DX3-213B |
|||
| HY-144310 | MedChemExpress | 10 mg | EUR 1558.47 |
|
Description: DX3-213B is a highly potent, orally active oxidative phosphorylation (OXPHOS) complex I inhibitor (IC50=3.6 nM). DX3-213B impairs ATP generation (IC50=11 nM), and blocks MIA PaCa-2 cell growth (GI50=11 nM). DX3-213B is used for the research of the pancreatic cancer[1]. |
|||
DX600 |
|||
| T35324-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: DX600 |
|||
DX600 |
|||
| T35324-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: DX600 |
|||
DX600 |
|||
| T35324-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: DX600 |
|||
DX600 |
|||
| T35324-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: DX600 |
|||
DX600 |
|||
| T35324-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: DX600 |
|||